Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Times Interest Earned (2020 - 2024)

Gyre Therapeutics (GYRE) has disclosed Times Interest Earned for 9 consecutive years, with $25.62 as the latest value for Q1 2024.

  • On a quarterly basis, Times Interest Earned rose 147.23% to $25.62 in Q1 2024 year-over-year; TTM through Dec 2024 was $51.31, a 161.99% increase, with the full-year FY2023 number at -$25.92, changed N/A from a year prior.
  • Times Interest Earned was $25.62 for Q1 2024 at Gyre Therapeutics, up from $10.36 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $25.62 in Q1 2024 to a low of -$376.82 in Q4 2020.
  • A 3-year average of -$113.61 and a median of $10.36 in 2023 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 147.23% in 2024; the steepest drop was 147.23% in 2024.
  • Gyre Therapeutics' Times Interest Earned stood at -$376.82 in 2020, then skyrocketed by 102.75% to $10.36 in 2023, then soared by 147.23% to $25.62 in 2024.
  • Per Business Quant, the three most recent readings for GYRE's Times Interest Earned are $25.62 (Q1 2024), $10.36 (Q1 2023), and -$376.82 (Q4 2020).